Confirm where the medication came from and whether the pharmacy or provider follows current rules
It contains the same active ingredient as the Wegovy injection (semaglutide, a GLP-1 receptor agonist that reduces appetite and slows gastric emptying) and is a once-daily tablet taken on an empty stomach, offering a needle-free alternative to the weekly injection
Standard reconstitution for a 5mg vial A 5mg vial of lyophilized tirzepatide powder contains exactly 5 milligrams of peptide
Importantly, this tolerance window doesn't mean the medication stops workingappetite suppression and weight loss benefits actually improve during weeks two through twelve as your body adjusts
Start your intake State-by-State Medicaid GLP-1 Coverage: What You Need to Know As of 2024, approximately 30 state Medicaid programs cover GLP-1 medications for weight loss, though many limit coverage to patients with BMI 30 kg/m plus at least one obesity-related comorbidity (hypertension, type 2 diabetes, sleep apnea, or cardiovascular disease)